SEI Investments’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-78,703
Closed -$711K 3338
2025
Q4
$711K Buy
+78,703
New +$588K ﹤0.01% 2337
2025
Q2
Sell
-35,764
Closed -$41.1K 2917
2025
Q1
$41.1K Hold
35,764
﹤0.01% 2691
2024
Q4
$78.3K Sell
35,764
-35
-0.1% -$79 ﹤0.01% 2617
2024
Q3
$78K Buy
+35,799
New +$82.3K ﹤0.01% 2593
2023
Q4
Sell
-19,541
Closed -$679K 2683
2023
Q3
$679K Buy
19,541
+5,410
+38% +$187K ﹤0.01% 2009
2023
Q2
$463K Sell
14,131
-1,182
-8% -$40.7K ﹤0.01% 2165
2023
Q1
$513K Sell
15,313
-753
-5% -$29.3K ﹤0.01% 2118
2022
Q4
$527K Buy
16,066
+4,452
+38% +$132K ﹤0.01% 1987
2022
Q3
$405K Buy
+11,614
New +$257K ﹤0.01% 2186

Other funds holding VTYX

SEI Investments's VTYX Position: Q1 2026 in Review

SEI Investments sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 78,703 shares — an estimated $711K sold.

SEI Investments first reported a position in VTYX in Q3 2022 and held it in 9 quarters. The position peaked at $711K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • SEI Investments reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • SEI Investments sold 78,703 Ventyx Biosciences shares in Q1 2026, an estimated $711K.
  • SEI Investments first reported a position in Ventyx Biosciences in Q3 2022 and held it in 9 quarters.
  • SEI Investments's Ventyx Biosciences position peaked at $711K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.